EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial Cells Offer a Better Option than Smooth Muscle Cells for the Treatment of Ischemic Limb Disease

Akazha Green iD, Hanyu Zhang, Bing Bo, Bijay Guragain, Yalin Wu iD, Yuhua Wei, Jianyi Zhang, Lei Ye

Cells · 2026

DOI: 10.3390/cells15171547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Akazha Green und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Alabama at Birmingham, Volker Hall, 1670 University Boulevard, Birmingham, AL 35233, USA. Hauptthemen laut MEDLINE: Ischemia, Endothelial Cells, Hindlimb, Myocytes, Smooth Muscle. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral arterial disease (PAD) is estimated to affect at least 10 million people in the United States and over 200 million individuals worldwide. The clinical manifestations of PAD range from impaired mobility and pain with activity to chronic limb-threatening ischemia with risk of eventual tissue loss. Despite the significant global prevalence and debilitating consequences of the disease, non-option patients remain largely undertreated. Recognizing that ECs are well-known for their therapeutic role in enhancing perfusion and neovascularization in mouse models of critical limb ischemia, we hypothesize that a synergy of ECs with SMCs may achieve better recovery of perfusion and neovascularization than ECs or SMCs alone. In this study, we compared the therapeutic efficacy of hiPSC-ECs, hiPSC-SMCs, and hiPSC-ECs + hiPSC-SMCs for the treatment of critical limb disease using a NOD-SCID mouse model of hind limb ischemia (HLI). A total of 1 × 106 hiPSC-ECs, 1 × 106 hiPSC-SMCs, or 0.5 × 106 hiPSC-ECs + 0.5 × 106 hiPSC-SMCs were intramuscularly injected into the ischemic limb of the mouse on day 3 after HLI induction. Laser Doppler was recorded on day 0 before, days 3 (i.e., before cell administration) and 31 after HLI induction. Compared with only basal medium injection, hiPSC-ECs alone most effectively improved perfusion (63.8% after normalized non-ischemic limb, p < 0.001) and neovascularization (total vessel density = 180.9/magnification, p < 0.001) followed by co-administration of hiPSC-ECs + hiPSC-SMCs (perfusion = 59%, p = 0.008 and total vessel density = 170.5, p = 0.002) compared with basal medium injection (perfusion = 39.7% and total vessel density = 107.2), while hiPSC-SMCs administration achieved mild to moderate improvement (perfusion = 48.9% and total vessel density = 159.5, p = 0.01). When profiles of secreted growth factors or cytokines were determined using a protein array, 34 growth factors or cytokines involved in angiogenesis were highly enriched (at least >50% increase) in a hiPSC-ECs conditioned medium, including basic fibroblast growth factor and vascular endothelial growth factor, while there were 14 in hiPSC-SMCs conditioned medium. In conclusion, our results demonstrate that hiPSC-ECs alone most effectively improved perfusion and neovascularization, followed by co-administration of hiPSC-ECs + hiPSC-SMCs, which may be due to the abundance of growth factors and cytokines secreted by hiPSC-ECs. Future studies are warranted to evaluate the therapeutic efficacy of hiPSC-EC and hiPSC-SMC co-transplantation in aged animals with metabolic and cardiovascular comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IschemiaEndothelial CellsHindlimbMyocytes, Smooth MusclePeripheral Arterial DiseaseAnimalsHumansInduced Pluripotent Stem CellsMiceMice, SCIDNeovascularization, PhysiologicMice, Inbred NODDisease Models, AnimalAngiogenesis

Stichwörter der Autor:innen

cell differentiationendothelial cellshuman induced pluripotent stem cellsischemic limb diseasesmooth muscle cells

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Alabama at Birmingham, Volker Hall, 1670 University Boulevard, Birmingham, AL 35233, USA.
  • Department of Medicine, Division of Cardiovascular Disease, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

ORCID-Profile: Akazha Green, Yalin Wu

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Green, A., Zhang, H., Bo, B., Guragain, B., Wu, Y., Wei, Y., Zhang, J., & Ye, L. (2026). Endothelial Cells Offer a Better Option than Smooth Muscle Cells for the Treatment of Ischemic Limb Disease. Cells. https://doi.org/10.3390/cells15171547

Vancouver

Green A, Zhang H, Bo B, Guragain B, Wu Y, Wei Y, et al. Endothelial Cells Offer a Better Option than Smooth Muscle Cells for the Treatment of Ischemic Limb Disease. Cells. 2026. doi:10.3390/cells15171547

BibTeX
@article{Green2026,
  author = {Green, Akazha and Zhang, Hanyu and Bo, Bing and Guragain, Bijay and Wu, Yalin and Wei, Yuhua and Zhang, Jianyi and Ye, Lei},
  title = {Endothelial Cells Offer a Better Option than Smooth Muscle Cells for the Treatment of Ischemic Limb Disease},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15171547}
}
Kostenlos starten →